Newron Pharmaceuticals S.p.A. (NWRN.SW)

CHF 8.0

(11.73%)

Inventory Summary of Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.'s latest annual inventory in 2023 was 1.00 EUR , down 0.0% from previous year.
Newron Pharmaceuticals S.p.A.'s latest quarterly inventory in 2024 Q2 was 2.44 Million EUR , down 0.0% from previous quarter.
Newron Pharmaceuticals S.p.A. reported annual inventory of 1.00 EUR in 2022, down 0.0% from previous year.
Newron Pharmaceuticals S.p.A. reported annual inventory of - EUR in 2021, down 0.0% from previous year.
Newron Pharmaceuticals S.p.A. reported quarterly inventory of 2.00 EUR for 2023 Q2, down 0.0% from previous quarter.
Newron Pharmaceuticals S.p.A. reported quarterly inventory of 1.00 EUR for 2023 FY, down 0.0% from previous quarter.

Annual Inventory Chart of Newron Pharmaceuticals S.p.A. (2023 - 2005)

Historical Annual Inventory of Newron Pharmaceuticals S.p.A. (2023 - 2005)

Year	Inventory	Inventory Growth
2023	1.00 EUR	0.0%
2022	1.00 EUR	0.0%
2021	- EUR	0.0%
2020	- EUR	-100.0%
2019	1.00 EUR	0.0%
2018	1.00 EUR	-99.98%
2017	5000.00 EUR	0.0%
2016	5000.00 EUR	-86.84%
2015	38 Thousand EUR	-62.75%
2014	102 Thousand EUR	-66.11%
2013	301 Thousand EUR	29.18%
2012	233 Thousand EUR	-5.28%
2011	246 Thousand EUR	-37.88%
2010	396 Thousand EUR	4.21%
2009	380 Thousand EUR	-42.16%
2008	657 Thousand EUR	25.62%
2007	523 Thousand EUR	-61.12%
2006	1.34 Million EUR	82.0%
2005	739 Thousand EUR	0.0%

Year	Inventory	Inventory Growth
2024 Q2	2.44 Million EUR	0.0%
2023 Q2	2.00 EUR	0.0%
2023 FY	1.00 EUR	0.0%
2023 Q4	1.00 EUR	0.0%
2022 Q2	- EUR	0.0%
2022 FY	1.00 EUR	0.0%
2022 Q4	1.00 EUR	0.0%
2021 FY	- EUR	0.0%
2021 Q4	- EUR	0.0%
2021 Q2	- EUR	0.0%
2020 Q4	- EUR	0.0%
2020 FY	- EUR	-100.0%
2020 Q2	- EUR	0.0%
2019 Q2	1.00 EUR	0.0%
2019 Q4	1.00 EUR	0.0%
2019 FY	1.00 EUR	0.0%
2018 Q4	1.00 EUR	0.0%
2018 FY	1.00 EUR	-99.98%
2018 Q2	5000.00 EUR	0.0%
2017 Q2	5000.00 EUR	0.0%
2017 FY	5000.00 EUR	0.0%
2017 Q4	5000.00 EUR	0.0%
2016 Q2	38 Thousand EUR	0.0%
2016 Q4	5000.00 EUR	0.0%
2016 FY	5000.00 EUR	-86.84%
2015 Q4	38 Thousand EUR	0.0%
2015 FY	38 Thousand EUR	-62.75%
2015 Q2	98 Thousand EUR	0.0%
2014 Q2	198 Thousand EUR	0.0%
2014 FY	102 Thousand EUR	-66.11%
2014 Q4	102 Thousand EUR	0.0%
2013 Q4	301 Thousand EUR	0.0%
2013 Q2	228 Thousand EUR	0.0%
2013 FY	301 Thousand EUR	29.18%
2012 Q2	227 Thousand EUR	0.0%
2012 Q4	233 Thousand EUR	0.0%
2012 FY	233 Thousand EUR	-5.28%
2011 Q2	395 Thousand EUR	0.0%
2011 FY	246 Thousand EUR	-37.88%
2011 Q4	246 Thousand EUR	0.0%
2010 Q2	466 Thousand EUR	0.0%
2010 FY	396 Thousand EUR	4.21%
2010 Q4	396 Thousand EUR	0.0%
2009 Q4	380 Thousand EUR	0.0%
2009 FY	380 Thousand EUR	-42.16%
2008 FY	657 Thousand EUR	25.62%
2007 FY	523 Thousand EUR	-61.12%
2006 FY	1.34 Million EUR	82.0%
2005 FY	739 Thousand EUR	0.0%

Peer Inventory Comparison of Newron Pharmaceuticals S.p.A.

Name	Inventory	Inventory Difference
Addex Therapeutics Ltd	- CHF	-Infinity%
BB Biotech AG	-2.63 Billion CHF	100.0%
Basilea Pharmaceutica AG	26.41 Million CHF	100.0%
Evolva Holding SA	- CHF	-Infinity%
Idorsia Ltd	59.14 Million CHF	100.0%
Kuros Biosciences AG	4.85 Million CHF	100.0%
Molecular Partners AG	- CHF	-Infinity%
Relief Therapeutics Holding AG	557 Thousand CHF	100.0%
Santhera Pharmaceuticals Holding AG	1.81 Million CHF	100.0%